Effects of a nutraceutical formulation based on the combination of antioxidants and ω-3 essential fatty acids in the expression of inflammation and immune response mediators in tears from patients with dry eye disorders

Clinical Interventions in Aging

Volumn 8, Issue , 2013, Pages 139-148

  Pinazo Durán, Maria D ^a   Galbis Estrada, Carmen ^a   Pons Vázquez, Sheila ^a   Cantú Dibildox, Jorge ^b   Marco Ramírez, Carla ^a   Benítez del Castillo, Javier ^b  

^a UNIVERSITY OF VALENCIA   (Spain)

^b HOSPITAL DE JEREZ   (Spain)

Author keywords

Aging; Cytokines; Essential polyunsaturated fatty acids; Nutraceutics; Tears; Women

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; AUTACOID; BIOLOGICAL FACTOR; BRUDYSEC; COPPER; CYSTEINE; DOCOSAHEXAENOIC ACID; DOCOSAPENTAENOIC ACID; GLUTATHIONE; ICOSAPENTAENOIC ACID; IMMUNE RESPONSE MEDIATOR; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MANGANESE; NUTRACEUTICAL; OMEGA 3 FATTY ACID; RETINOL; SELENIUM; TYROSINE; UNCLASSIFIED DRUG; VASCULOTROPIN; ZINC;

ADULT; AGED; ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; DRUG EFFICACY; DRUG FORMULATION; DRY EYE; EYE EXAMINATION; FEMALE; FLOW CYTOMETRY; HUMAN; IMMUNE RESPONSE; LACRIMAL FLUID; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OPEN STUDY; OUTCOME ASSESSMENT; PROSPECTIVE STUDY; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SCHIRMER TEST; TREATMENT DURATION;

AGING; CYTOKINES; ESSENTIAL POLYUNSATURATED FATTY ACIDS; NUTRACEUTICS; TEARS; WOMEN;

ADULT; AGED; AGED, 80 AND OVER; ANTIOXIDANTS; DIETARY SUPPLEMENTS; DRY EYE SYNDROMES; FATTY ACIDS, OMEGA-3; FEMALE; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-10; INTERLEUKIN-1BETA; INTERLEUKIN-6; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; TEARS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84873649381     PISSN: 11769092     EISSN: 11781998     Source Type: Journal    
DOI: 10.2147/CIA.S40640     Document Type: Article

References (61)

1. Perry HD. Dry eye disease: pathophysiology, classification, and diagnosis. Am J Manag Care. 2008;14(Suppl 3):S79-S87.
2. Tavares Fde P, Fernandes RS, Bernardes TF, Bonfioli AA, Soares EJ. Dry eye disease. Semin Ophthalmol. 2010;25(3):84-93.
3. Labbé A, Brignole-Baudouin F, Baudouin C. [Ocular surface investigations in dry eye]. J Fr Ophtalmol. 2007;30(1):76-97. French.
4. Schein OD, Muñoz B, Tielsch JM, Bandeen-Roche K, West S. Prevalence of dry eye among the elderly. Am J Ophthalmol. 1997; 124(6):723-728.
5. Muñoz B, West SK, Rubin GS, et al. Causes of blindness and visual impairment in a population of older Americans: The Salisbury Eye Evaluation Study. Arch Ophthalmol. 2000;118(6):819-825.
6. Moss SE, Klein R, Klein BE. Long-term incidence of dry eye in an older population. Optom Vis Sci. 2008;85(8):668-674.
7. Schaumberg DA, Sullivan DA, Buring JE, Dana MR. Prevalence of dry eye syndrome among US women. Am J Ophthalmol. 2003;136(2):318-326.
8. Gipson IK, Spurr-Michaud S, Argüeso P, Tisdale A, Ng TF, Russo CL. Mucin gene expression in immortalized human corneal-limbal and conjunctival epithelial cell lines. Invest Ophthalmol Vis Sci. 2003;44(6): 2496-2506.
9. Baudouin C. [A new approach for better comprehension of diseases of the ocular surface]. J Fr Ophtalmol. 2007;30(3):239-246. French.
10. VanDerMeid KR, Su SP, Krenzer KL, Ward KW, Zhang JZ. A method to extract cytokines and matrix metalloproteinases from Schirmer strips and analyze using Luminex. Mol Vis. 2011;17:1056-1063.
11. Enríquez-de-Salamanca A, Castellanos E, Stern ME, et al. Tear cytokine and chemokine analysis and clinical correlations in evaporative-type dry eye disease. Mol Vis. 2010;16:862-873.
12. Baudouin C, Brignole F, Becquet F, Pisella PJ, Goguel A. Flow cytometry in impression cytology specimens. A new method for evaluation of conjunctival inflammation. Invest Ophthalmol Vis Sci. 1997;38(7):1458-1464.
13. Vignali DA. Multiplexed particle-based flow cytometric assays. J Immunol Methods. 2000;243(1-2):243-255.
14. Massingale ML, Li X, Vallabhajosyula M, Chen D, Wei Y, Asbell PA. Analysis of inflammatory cytokines in the tears of dry eye patients. Cornea. 2009;28(9):1023-1027.
15. Halliwell B. Free radicals and antioxidants: updating a personal view. Nutr Rev. 2012;70(5):257-265.
16. Zanon-Moreno V, Marco-Ventura P, Lleo-Perez AV, et al. Oxidative stress in primary open-angle glaucoma. J Glaucoma. 2008;17(4): 263-268.
17. Berthoud VM, Beyer EC. Oxidative stress, lens gap junctions, and cataracts. Antioxid Redox Signal. 2009;11(2):339-353.
18. Garcia-Medina JJ, Pinazo-Duran MD, Garcia-Medina M, Zanon-Moreno V, Pons-Vazquez S. A 5-year follow-up of antioxidant supplementation in type 2 diabetic retinopathy. Eur J Ophthalmol. 2011;21(5):637-643.
19. Suzuki M, Tsujikawa M, Itabe H, et al. Chronic photo-oxidative stress and subsequent MCP-1 activation as causative factors for age-related macular degeneration. J Cell Sci. 2012;125(Pt 10):2407-2415.
20. Venkata SJ, Narayanasamy A, Srinivasan V, et al. Tear ascorbic acid levels and the total antioxidant status in contact lens wearers: a pilot study. Indian J Ophthalmol. 2009;57(4):289-292.
21. Pinazo-Durán MD, Zanón-Moreno V, García-Medina JJ, Gallego-Pinazo R. Evaluation of presumptive biomarkers of oxidative stress, immune response and apoptosis in primary open-angle glaucoma. Curr Opin Pharmacol. 2012;13(1):98-107.
22. Medzhitov R, Janeway C Jr. Innate immunity. N Engl J Med. 2000;343(4):338-344.
23. Zoukhri D. Effect of inflammation on lacrimal gland function. Exp Eye Res. 2006;82(5):885-898.
24. Krabbe KS, Pedersen M, Bruunsgaard H. Inflammatory mediators in the elderly. Exp Gerontol. 2004;39(5):687-699.
25. Stevenson W, Chauhan SK, Dana R. An immune-mediated ocular surface disorder. Arch Ophthalmol. 2012;130(1):90-100.
26. Yoshida N, Ikeda Y, Notomi S, et al. Laboratory evidence of sustained chronic inflammatory reaction in retinitis pigmentosa. Ophthalmology. Epub September 15, 2012.
27. Gallego-Pinazo R, Marsiglia M, Mrejen S, Yannuzzi LA. Outer retinal tubulations in chronic central serous chorioretinopathy. Graefes Arch Clin Exp Ophthalmol. Epub September 7, 2012.
28. Grus FH, Podust VN, Bruns K, et al. SELDI-TOF-MS ProteinChip array profiling of tears from patients with dry eye. Invest Ophthalmol Vis Sci. 2005;46(3):863-876.
29. Higuchi A, Kawakita T, Tsubota K. IL-6induction in desiccated corneal epithelium in vitro and in vivo. Mol Vis. 2011;17:2400-2406.
30. Choy CK, Cho P, Chung WY, Benzie IF. Water-soluble antioxidants in human tears: effect of the collection method. Invest Ophthalmol Vis Sci. 2001;42(13):3130-3134.
31. Stevenson W, Chauhan SK, Dana R. Dry eye disease: an immune-mediated ocular surface disorder. Arch Ophthalmol. 2012;130(1):90-100.
32. Fredman G, Serhan CN. Specialized proresolving mediator targets for RvE1 and RvD1in peripheral blood and mechanisms of resolution. Biochem J. 2011;437(2):185-197.
33. Swenor BK, Bressler S, Caulfield L, West SK. The impact of fish and shellfish consumption on age-related macular degeneration. Ophthalmology. 2010;117(12):2395-2401.
34. Chong EW, Kreis AJ, Wong JY, Simpson JA, Guymer RH. Dietary-3 fatty acid and fish intake in the primary prevention of age-related macular degeneration: a systematic review and meta-analysis. Arch Ophthalmol. 2008;126(6):826-833.
35. Licinio J, Wong ML. The role of inflammatory mediators in the biology of major depression: central nervous system cytokines modulate the biological substrate of depressive symptoms, regulate stress-responsive systems, and contribute to neurotoxicity and neuroprotection. Mol Psychiatry. 1999;4(4):317-327.
36. Ren H, Magulike N, Ghebremeskel K, Crawford M. Primary open-angle glaucoma patients have reduced levels of blood docosahexaenoic and eicosapentaenoic acids. Prostaglandins Leukot Essent Fatty Acids. 2006;74(3):157-163.
37. Pinazo-Duran MD, Boscá-Gomar L. [Anti-inflammatory properties of polyunsaturated fatty acid omega 3 Indications in ophthalmology]. Arch Soc Esp Oftalmol. 2012;87(7):203-205. Spanish.
38. Sapieha P, Stahl A, Chen J, et al. 5-Lipoxygenase metabolite 4-HDHA is a mediator of the antiangiogenic effect of ω-3 polyunsaturated fatty acids. Sci Transl Med. 2011;3(69):69ra12.
39. Rosenberg ES, Asbell PA. Essential fatty acids in the treatment of dry eye. Ocular Surf. 2010;8(1):18-28.
40. Lane SS, DuBiner HB, Epstein RJ, et al. A new system, the LipiFlow, for the treatment of meibomian gland dysfunction. Cornea. 2012;31(4):396-404.
41. Stewart M. The validity of an interview to assess a patient's drug taking. Am J Prev Med. 1987;3(2):95-100.
42. Schiffman RM, Christianson MD, Jacobsen G, Hirsch JD, Reis BL. Reliability and validity of the Ocular Surface Disease Index. Arch Ophthalmol. 2000;118(5):615-621.
43. Savini G, Prabhawasat P, Kojima T, Grueterich M, Espana E, Goto E. The challenge of dry eye diagnosis. Clin Ophthalmol. 2008;2(1):31-55.
44. Brignole F, Pisella PJ, Goldschild M, De Saint Jean M, Goguel A, Baudouin C. Flow cytometric analysis of inflammatory markers in conjunctival epithelial cells of patients with dry eyes. Invest Ophthalmol Vis Sci. 2000;41(6):1356-1363.
45. Higuchi A, Kawakita T, Tsubota K. IL-6induction in desiccated corneal epithelium in vitro and in vivo. Mol Vis. 2011;17:2400-2406.
46. Enríquez-de-Salamanca A, Castellanos E, Stern ME, et al. Tear cytokine and chemokine analysis and clinical correlations in evaporative-type dry eye disease. Mol Vis. 2010;16:862-873.
47. Tuominen IS, Tervo TM, Teppo AM, Valle TU, Grönhagen-Riska C, Vesaluoma MH. Human tear fluid PDGF-BB, TNF-alpha and TGF-beta1 vs corneal haze and regeneration of corneal epithelium and subbasal nerve plexus after PRK. Exp Eye Res. 2001;72(6):631-641.
48. Boehm N, Riechardt AI, Wiegand M, Pfeiffer N, Grus FH. Proinflammatory cytokine profiling of tears from dry eye patients by means of antibody microarrays. Invest Ophthalmol Vis Sci. 2011;52(10):7725-7730
49. Brignole-Baudouin F, Baudouin C, Aragona P, et al. A multicentre, double-masked, randomized, controlled trial assessing the effect of oral supplementation of omega-3 and omega-6 fatty acids on a conjunctival inflammatory marker in dry eye patients. Acta Ophthalmol. 2011;89(7):e591-e597.
50. Abu El-Asrar AM, Al-Mansouri S, Tabbara KF, Missotten L, Geboes K. Immunopathogenesis of conjunctival remodelling in vernal keratoconjunctivitis. Eye (Lond). 2006;20(1):71-79.
51. Yoo SA, Kwok SK, Kim WU. Proinflammatory role of vascular endothelial growth factor in the pathogenesis of rheumatoid arthritis: prospects for therapeutic intervention. Mediators Inflamm. 2008;2008:129873.
52. Wang Y, Mao XO, Xie L, et al. Vascular endothelial growth factor overexpression delays neurodegeneration and prolongs survival in amyotrophic lateral sclerosis mice. J Neurosci. 2007;27(2):304-307.
53. Rand AL, Asbell PA. Nutritional supplements for dry eye syndrome. Curr Opin Ophthalmol. 2011;22(4):279-282.
54. Roncone M, Bartlett H, Eperjesi F. Essential fatty acids for dry eye: A review. Cont Lens Anterior Eye. 2010;33(2):49-54.
55. Cortina MS, Bazan HE. Docosahexaenoic acid, protectins and dry eye. Curr Opin Clin Nutr Metab Care. 2011;14(2):132-137.
56. Li N, He J, Schwartz CE, Gjorstrup P, Bazan HE. Resolvin E1 improves tear production and decreases inflammation in a dry eye mouse model. J Ocul Pharmacol Ther. 2010;26(5):431-439.
57. Moss SE, Klein R, Klein BE. Prevalence of and risk factors for dry eye syndrome. Arch Ophthalmol. 2000;118(9):1264-1268.
58. Lee AJ, Lee J, Saw SM, et al. Prevalence and risk factors associated with dry eye symptoms: a population based study in Indonesia. Br J Ophthalmol. 2002;86:1347-1351.
59. Chia EM, Mitchell P, Rochtchina E, Lee AJ, Maroun R, Wang JJ. Prevalence and associations of dry eye syndrome in an older population: the Blue Mountains Eye Study. Clin Experiment Ophthalmol. 2003;31(3):229-232.
60. Viso E, Rodriguez-Ares MT, Gude F. Prevalence of and associated factors for dry eye in a Spanish adult population (the Salnes Eye Study). Ophthalmic Epidemiol. 2009;16(1):15-21.
61. Luo L, Li DQ, Doshi A, Farley W, Corrales RM, Pflugfelder SC. Experimental dry eye stimulates production of inflammatory cytokines and MMP-9 and activates MAPK signaling pathways on the ocular surface. Invest Ophthalmol Vis Sci. 2004;45(12):4293-4301.